Single capripoxvirus recombinant vaccine for the protection of cattle against rinderpest and lumpy skin disease.

Abstract

A recombinant capripoxvirus has been constructed containing a full-length cDNA of the fusion protein gene of rinderpest virus. The gene was inserted in the thymidine kinase gene of the capripox genome under the control of the vaccinia virus major late promoter p11 together with the Escherichia coli gpt gene in the opposite orientation under the control of the vaccinia early/late promoter p7.5. A vaccine prepared from this recombinant virus protected cattle against clinical rinderpest after a lethal challenge with a virulent virus isolate. In addition, the vaccine protected the cattle against lumpy skin disease.

• Authors: C H Romero, T Barrett, S A Evans, R P Kitching, P D Gershon, C Bostock, D N Black
• Journal: Vaccine (Vaccine) Vol. 11 Issue 7 Pg. 737-42 ( 1993) ISSN: 0264-410X [Print] Netherlands
• PMID: 8342321 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Antibodies, Viral
• DNA, Viral
• F protein, Rinderpest virus
• Glycoproteins
• Membrane Proteins
• Vaccines, Synthetic
• Viral Fusion Proteins
• Viral Vaccines

Topics

• Animals
• Antibodies, Viral (biosynthesis)
• Cattle
• DNA, Viral (chemistry, genetics)
• Escherichia coli (genetics)
• Gene Expression
• Glycoproteins (genetics, immunology)
• Lumpy Skin Disease (prevention & control)
• Male
• Membrane Proteins
• Poxviridae (genetics, immunology)
• Rinderpest (prevention & control)
• Rinderpest virus (genetics, immunology)
• Vaccines, Synthetic (immunology)
• Viral Fusion Proteins (genetics, immunology)
• Viral Vaccines (immunology)